NL930104I2 - Heparinefragmenten met selectieve anticoagulatie activiteit en werkwijze ter bereiding daarvan. - Google Patents

Heparinefragmenten met selectieve anticoagulatie activiteit en werkwijze ter bereiding daarvan.

Info

Publication number
NL930104I2
NL930104I2 NL930104C NL930104C NL930104I2 NL 930104 I2 NL930104 I2 NL 930104I2 NL 930104 C NL930104 C NL 930104C NL 930104 C NL930104 C NL 930104C NL 930104 I2 NL930104 I2 NL 930104I2
Authority
NL
Netherlands
Prior art keywords
heparin fragments
preparation
anticoagulant activity
selective
sulphate
Prior art date
Application number
NL930104C
Other languages
English (en)
Dutch (nl)
Other versions
NL930104I1 (nl
Original Assignee
Kabipharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20336970&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL930104(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kabipharmacia Ab filed Critical Kabipharmacia Ab
Publication of NL930104I1 publication Critical patent/NL930104I1/nl
Publication of NL930104I2 publication Critical patent/NL930104I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
NL930104C 1979-01-08 1993-01-28 Heparinefragmenten met selectieve anticoagulatie activiteit en werkwijze ter bereiding daarvan. NL930104I2 (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7900164 1979-01-08

Publications (2)

Publication Number Publication Date
NL930104I1 NL930104I1 (nl) 1993-10-01
NL930104I2 true NL930104I2 (nl) 1997-02-03

Family

ID=20336970

Family Applications (1)

Application Number Title Priority Date Filing Date
NL930104C NL930104I2 (nl) 1979-01-08 1993-01-28 Heparinefragmenten met selectieve anticoagulatie activiteit en werkwijze ter bereiding daarvan.

Country Status (11)

Country Link
US (1) US4303651A (https=)
EP (1) EP0014184B2 (https=)
JP (1) JPS6344764B2 (https=)
AT (1) ATE8998T1 (https=)
CA (1) CA1136620A (https=)
DE (1) DE3068924D1 (https=)
DK (1) DK160764C (https=)
NL (1) NL930104I2 (https=)
NO (1) NO150801C (https=)
SU (1) SU1209033A3 (https=)
WO (1) WO1980001383A1 (https=)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692435A (en) * 1978-11-06 1987-09-08 Choay, S.A. Mucopolysaccharide composition having a regulatory action on coagulation, medicament containing same and process of preparation
US4500519A (en) * 1978-11-06 1985-02-19 Choay S.A. Mucopolysaccharides having biological properties, preparation and method of use
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
SE449753B (sv) * 1978-11-06 1987-05-18 Choay Sa Mukopolysackaridkomposition med reglerande verkan pa koagulation, lekemedel innehallande densamma samt forfarande for framstellning derav
FR2440376A1 (fr) * 1978-11-06 1980-05-30 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
FR2482611B1 (fr) * 1980-05-14 1986-03-07 Pharmindustrie Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments
US4438261A (en) 1980-05-19 1984-03-20 Riker Laboratories, Inc. Anticoagulant substance
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
WO1982001377A1 (en) * 1980-10-09 1982-04-29 Lill Helmut Method for determining a bm-antithrombin
FR2503714B1 (fr) * 1981-04-10 1986-11-21 Choay Sa Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
FR2504535B1 (fr) * 1981-04-28 1987-08-14 Choay Sa Disaccharides derives d'un acide uronique et d'une glucosamine et compositions pharmaceutiques les contenant pour le controle de la coagulation sanguine
US4818816A (en) * 1981-04-28 1989-04-04 Choay, S.A. Process for the organic synthesis of oligosaccharides and derivatives thereof
FR2535324A1 (fr) * 1982-10-27 1984-05-04 Choay Sa Station perfectionnee pour l'epuration d'eaux usees
EP0066908B1 (en) 1981-05-21 1985-08-28 Akzo N.V. New anti-thromboticum based on polysacharides, method for its preparation and pharmaceutical compositions
US4396762A (en) * 1981-08-24 1983-08-02 Massachusetts Institute Of Technology Heparinase derived anticoagulants
CA1265132A (en) * 1982-01-15 1990-01-30 Mahmoud Nassr Process for the organic synthesis of oligosaccharides and derivatives thereof
AU563351C (en) * 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
US4539398A (en) * 1982-01-22 1985-09-03 Riker Laboratories, Inc. Affinity fractionation of heparin on immobilized Concanavalin A
EP0098814B1 (en) 1982-06-10 1986-10-15 KabiVitrum AB Antithrombin-heparin complex
CA1195322A (en) * 1982-07-19 1985-10-15 Eduardo Amaya Process for manufacturing low molecular weight heparins by depolymerization of normal heparin
FR2538404B1 (https=) * 1982-12-28 1985-08-23 Anic Spa
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
FR2548672A1 (fr) * 1983-07-04 1985-01-11 Pharmuka Lab Oligosaccharides sulfates et leur utilisation comme medicaments
GB8614189D0 (en) * 1986-06-11 1986-07-16 Leo Pharm Prod Ltd Pharmaceutical composition
US4942156A (en) * 1986-08-20 1990-07-17 Hepar Industries, Inc. Low molecular weight heparin derivatives having improved anti-Xa specificity
US4745106A (en) * 1986-08-20 1988-05-17 Griffin Charles C Heparin derivatives having improved anti-Xa specificity
IT1213384B (it) * 1986-11-24 1989-12-20 Lab Derivati Organici Mediolan Processo per la preparazione controllata di gilcosaminoglicani a basso peso molecolare.
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
IT1230582B (it) 1988-10-21 1991-10-28 Opocrin S P A Lab Farmabiologi Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica
WO1991015217A1 (en) * 1990-04-06 1991-10-17 Washington University Anticoagulant oligosaccharides
USRE38743E1 (en) 1990-06-26 2005-06-14 Aventis Pharma S.A. Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events
US5665379A (en) * 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
FI921689L (fi) * 1991-04-16 1992-10-17 Seikagagu Kogyo Kabushiki Kais Oligosackarid med affinitet foer fibroblasttillvaextfaktor och foerfarande foer framstaellning av denna
SE9101155D0 (sv) * 1991-04-18 1991-04-18 Kabi Pharmacia Ab Novel heparin derivatives
GB9206291D0 (en) * 1992-03-23 1992-05-06 Cancer Res Campaign Tech Oligosaccharides having growth factor binding affinity
DE4217916C2 (de) * 1992-05-30 1995-05-18 Job Prof Dr Med Harenberg N-Alkylamin- und N-Arylalkylaminderivate von Heparin, Verfahren zu ihrer Herstellung und ihrer Verwendung
GB9306255D0 (en) * 1993-03-25 1993-05-19 Cancer Res Campaign Tech Heparan sulphate oligosaccharides having hepatocyte growth factor binding affinity
FR2704861B1 (fr) * 1993-05-07 1995-07-28 Sanofi Elf Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.
SE9302135D0 (sv) * 1993-06-18 1993-06-18 Kabi Pharmacia Ab New pharmaceutical composition
EP0735050B1 (en) * 1995-03-31 2002-09-25 Hamilton Civic Hospitals Research Development, Inc. Compositions for inhibiting thrombogenesis
AU754936B2 (en) * 1996-11-27 2002-11-28 Aventis Pharmaceuticals Inc. Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound
AU7753898A (en) * 1997-06-06 1998-12-21 Hamilton Civic Hospitals Research Development, Inc. Modified low molecular weight heparin that inhibits clot associated coagulation factors
US7412332B1 (en) 1999-04-23 2008-08-12 Massachusetts Institute Of Technology Method for analyzing polysaccharides
CZ20014665A3 (cs) * 1999-06-30 2002-05-15 Hamilton Civic Hospitals Research Development, Inc Prostředek s obsahem heparinu se střední molekulovou hmotností
JP2002097143A (ja) * 2000-07-18 2002-04-02 Koyo Chemical Kk 血流改善剤及び血栓予防治療剤または食品
US20040038932A1 (en) * 2000-09-08 2004-02-26 Jack Hirsh Antithrombotic compositions
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および／または線溶系酵素阻害剤との組み合わせからなる医薬
US6933372B2 (en) 2003-03-07 2005-08-23 Warner-Lambert Company Method to produce a solid form of heparin
EP1677831A1 (en) * 2003-06-05 2006-07-12 Gencell S.A. Plasmid encoding fibroblast growth factor for the treatment of hypercholesterolemia or diabetes associated angiogenic defects
ITMI20031679A1 (it) * 2003-08-29 2005-02-28 Opocrin Spa Processo per la produzione di eparine a basso peso
US20050096294A1 (en) * 2003-10-31 2005-05-05 Takashi Komai Novel anti-coagulant
EP1582531A1 (en) * 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
EP1792621B1 (en) 2005-11-30 2012-04-04 Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni" Orally administrable heparin derivatives
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
ES2567079T3 (es) * 2007-11-02 2016-04-19 Momenta Pharmaceuticals, Inc. Composiciones de polisacáridos que no son anticoagulantes
AU2009250803A1 (en) * 2008-05-20 2009-11-26 Crystal Clear Partnership Separation of polysaccharides by charge density gradient
ES2340902B1 (es) * 2008-07-01 2011-05-03 Laboratorios Farmaceuticos Rovi, S.A. Composicion farmaceutica con glicosaminoglicanos y su uso en tratamiento de ulceras cronicas.
US9387256B2 (en) 2010-04-16 2016-07-12 Momenta Pharmaceuticals, Inc. Tissue targeting
WO2011159770A2 (en) 2010-06-17 2011-12-22 Momenta Pharmaceuticals, Inc. Methods and compositions for modulating hair growth
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
RU2617764C2 (ru) 2011-12-19 2017-04-26 Дилафор Аб Неантикоагулянтные гликозаминогликаны, содержащие повторяющиеся дисахаридные звенья, и их медицинское применение
US10016449B2 (en) 2013-05-28 2018-07-10 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
RU2612813C1 (ru) * 2015-12-07 2017-03-13 Павел Андреевич Канаев Способ получения гепарина
JP2021513593A (ja) 2018-02-14 2021-05-27 バイオロジカル イー リミテッド ダルテパリンナトリウムを調製する改善された方法
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
JP2022540849A (ja) 2019-07-09 2022-09-20 オプティムヴィア、エルエルシー 抗凝固性多糖類の合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3135660A (en) * 1956-11-09 1964-06-02 Riker Laboratories Inc Method for purifying sulfated carbohydrates with oxidizing agents
US3066076A (en) * 1958-12-15 1962-11-27 Fo We Forschungs Und Verwertun Soluble heparin product and process for preparing same
FR2100735B1 (https=) * 1970-06-08 1974-08-30 Mar Pha Etu Expl Marques
DE2148011C3 (de) * 1970-10-05 1978-11-09 Aminkemi Ab Verfahren zum Herstellen nichtthrombogener Kunststoffoberflächen
US3766167A (en) * 1971-03-26 1973-10-16 Research Corp Orally active anticoagulant
GB1399824A (en) * 1971-08-16 1975-07-02 Mar Pha Etu Expl Marques Heparin esters
IT1083903B (it) * 1977-08-09 1985-05-25 Lobo Srl Oligo-eteropolisaccaridi con attivita' eparinosimili,procedimento per il loro ottenimento e relative composizioni terapeutiche

Also Published As

Publication number Publication date
JPS6344764B2 (https=) 1988-09-06
DE3068924D1 (en) 1984-09-20
JPS56500066A (https=) 1981-01-22
DK380280A (da) 1980-09-05
DK160764C (da) 1991-09-23
WO1980001383A1 (en) 1980-07-10
EP0014184A3 (en) 1980-10-01
NO150801B (no) 1984-09-10
NO150801C (no) 1984-12-27
US4303651A (en) 1981-12-01
CA1136620A (en) 1982-11-30
SU1209033A3 (ru) 1986-01-30
ATE8998T1 (de) 1984-09-15
DK160764B (da) 1991-04-15
EP0014184B2 (en) 1989-10-18
EP0014184B1 (en) 1984-08-15
EP0014184A2 (en) 1980-08-06
NO802626L (no) 1980-09-05
NL930104I1 (nl) 1993-10-01

Similar Documents

Publication Publication Date Title
NL930104I2 (nl) Heparinefragmenten met selectieve anticoagulatie activiteit en werkwijze ter bereiding daarvan.
FR2310354A1 (fr) Glucopyranosido-1,6-mannite, son procede de fabrication et son utilisation en tant que succedane du sucre
IT1167610B (it) Interfreron ibrido multiclasse, composizione farmaceutica che lo contiene e procedimento di produzione
IT8319164A0 (it) Derivati della 5-metiltiopirimidina, processo diloro preparazione e fungicidi contenenti gli stessi come ingredienti attivi.
FR2296849A1 (fr) Plasma sanguin stable, son procede de preparation et ses applications
IT1098253B (it) Propenil-ammine,procedimenti per la loro produzione,e composizioni farmaceutiche che le contengono
IT1112966B (it) Processo e reagente per la determinazione della eparina biologicamente attiva nel plasma
EP0245813A3 (en) Edta-free heparins, heparin fractions and fragments, processes for their preparation and pharmaceutical compositions containing them
IL53901A (en) Meta-(ergoline-8 -carboxamido)benzamides (or benzenesulfonamides),their production and pharmaceutical compositions containing them
NO810660L (no) Nye lignosulfonsyrederivater, fremgangsmaate for fremstilling av disse og anvendelse av dem som additiver
FR2322132A1 (fr) Nouvelles (trifluoromethylphenoxy)-phenylurees, leur procede de preparation et leur application comme herbicides
BE840470A (fr) Nouvel antibiotique, son procede de preparation et ses applications phytopharmaceutiques.
RO82014A (ro) Procedeu pentru prepararea unor derivati de 4-chinolina cu activitateantihipertensiva
BE761116A (fr) Nouvelles (1,2,4)-triazolo-(3,2-c) (1,2,4)-triazinones, leur procede depreparation et leur application comme herbicides
BE844065A (fr) Nouvelles 2-phenylimino-thiazolines substituees, leur procede de preparation et compositions ectoparasiticides les contenant
IT1167820B (it) Derivati del benzossazolone,procedimenti per la preparazione di questi e composizioni che li contengono
DK140152B (da) Fremgangsmåde til fremstilling af et antibioticum kaldet fortimicin C eller syreadditionssalte deraf.
DK140314B (da) Analogifremgangsmåde til fremstilling af beta-D-1(6-amino-9H-purin-9-yl)-1-deoxy-2,3-di-O-nitroribofuranuronsyreethylamid.
RO86858A (ro) Procedeu pentru prepararea unor derivati de acid -2-feno0i-propionic ai pentitelor
FR2472608B1 (fr) Nouvelle glucose-6-phosphate-deshydrogenase, son procede de preparation et compositions coenzymatiques la contenant
CH513788A (fr) Procédé de préparation sélective d'alcool, estérifié de façon concomitante
BE846471A (fr) Procede de preparation de 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-t-butylaminoethyl) pyridine, et intermediaires appropries
FR2349578A1 (fr) Nouvelles 2-phenylimino-thiazolines, leur procede de preparation et compositions ectoparasiticides les contenant
FR2314198A1 (fr) D-homo 5a-pregnene-9(11)ones-20, et leur procede de preparation
BE866934A (fr) Nouveaux polysaccharide, son procede de preparation et compositions pharmaceutiques en contenant